VALID Accommodations for Academic Medical Centers and Other Lab Tests

BOSTON—AdvaMed, the Medtech Association, today announced Scott Garrett as the 2026 recipient of the AdvaMedDx Lifetime of Leadership & Service Award, honoring his more than 45 years of leadership across diagnostics, life sciences, medical products, specialty distribution, and laboratory services.

WASHINGTON, D.C.—AdvaMed®, the Medtech Association, today announced Vincent A. “Vince” Forlenza, former chairman and CEO of BD (Becton, Dickinson and Company), as the recipient of the 2026 AdvaMed Lifetime Achievement Award. Forlenza will receive the award during The MedTech Conference in Boston Oct. 18-21.

The State Medtech Alliance (SMTA) connects state and regional medtech associations across the U.S. to share best practices, coordinate advocacy, and improve patient access to medical technology.

Behind every policy conversation is a patient waiting for access to the care and technology they need. In this edition of AdvaMed in Action, Bobby Patrick explores how collaboration among patient advocates, medtech companies, state partners and policy leaders can help advance patient access and turn shared priorities into meaningful action.

WINNIPEG, MANITOBA, CANADA, August 20, 2026 /EINPresswire.com/ — Cubresa Inc., a global leader in clinical and preclinical molecular imaging technologies, today announced that it has received FDA 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its groundbreaking Cubresa BrainPET™ scanner.

WASHINGTON—Scott Whitaker, president and CEO of AdvaMed, the medtech association, made the following comment on President Trump’s nomination of Dr. Heidi Overton to serve as FDA commissioner. 

WASHINGTON, D.C. – AdvaMed today announced that Juan Carlos “JC” Scott has been appointed Chief Strategy Officer and Executive Director of AdvaMed Accel, a newly created leadership position focused on accelerating engagement with emerging medical technology companies and strengthening AdvaMed’s role at the center of the innovation ecosystem.

In this op-ed published in The Washington Times, AdvaMed® President and CEO Scott Whitaker explains why policymakers seeking to lower health care costs should look closely at the value medtech delivers every day